Management of dabigatran-induced bleeding: expert statement.
The interdisciplinary group of experts has compiled a clinical guidance for manifest dabigatran-induced haemorrhage and envisaged invasive interventions on patients under dabigatran. It recommends an escalation of treatment measures as summarized in a pocket guide (see electronic supplementary material online and insert in the print issue).
Department of Anesthesia and Intensive Care, Medical University Innsbruck, Innsbruck, Austria.
Dietmar
D
Fries
Alexander
A
Giurea
Manfred
M
Gütl
Walter-Michael
WM
Halbmayer
Sibylle
S
Kozek-Langenecker
Andreas
A
Pachucki
Franz
F
Roithinger
Barbara
B
Steinlechner
Heinrich
H
Thaler
Ansgar
A
Weltermann
D000284:Administration, Oral; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects; D001317:Austria; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D001780:Blood Coagulation Tests / Q000592:standards*; D000069604:Dabigatran; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016343:Monitoring, Intraoperative / Q000592:standards; D019106:Postoperative Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D013927:Thrombosis / Q000517:prevention & control*; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran